Fig. 8From: Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathwaysValidation of the synergistic effect of the drug combination targeting both EGFR and VEGFR. a Prediction of the synergistic effect of the drug combination targeting both EGFR and VEGFR. b Experimental validation using in vivo data of DC101 (EGFR inhibitor), cetuximab (VEGFR inhibitor) and their combinationBack to article page